Foster City, CA, United States of America

Xiaodi Deng

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Dren Bio, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaodi Deng. Retrieved from https://idiyas.com/inventor/xiaodi-deng-1w4btha9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaodi Deng: Innovator in Antibody Technology

Introduction

Xiaodi Deng is a prominent inventor based in Foster City, California, known for her contributions to the field of antibody technology. With a unique focus on innovative methods of targeting human Dectin-1, she has made significant strides in biomedical research.

Latest Patents

Deng holds a patent for "Anti-Dectin-1 antibodies and methods of use thereof." This patent describes antibodies that specifically bind to human Dectin-1, detailing multispecific and bispecific binding molecules, along with methods relating to their use and production. Her work reflects a commitment to advancing therapeutic options in immunology.

Career Highlights

Throughout her career, Xiaodi Deng has been associated with Dren Bio, Inc., a company dedicated to pioneering advancements in antibody therapeutics. Her background in biochemistry and research has been instrumental in shaping her work and driving innovation within her field.

Collaborations

Deng has collaborated with esteemed colleagues such as Panagiotis Fotakis and Andrew P. Ah Young-Chapon, combining their expertise to enhance the impact of their research. Together, they strive to push the boundaries of what is possible in antibody-based therapies.

Conclusion

Xiaodi Deng's innovative spirit and dedication to her work are evident in her patent and collaborations. As she continues to develop groundbreaking technologies at Dren Bio, Inc., her contributions are poised to play a significant role in the future of immunological treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…